Opinion

Roupen Odabashian: Writing medical notes is very subjective: Some AI scribe can help

Photo from Roupen Odabashian/LinkedIn

Apr 15, 2024, 13:36

Roupen Odabashian: Writing medical notes is very subjective: Some AI scribe can help

Roupen Odabashian shared a post on LinkedIn:

”I remember in residency, I spent the first two months learning the style of note writing for each attending because I had to write my notes according to their preference.

Writing medical notes is very subjective; some physicians write very detailed notes, some write very brief notes, and some fall in between.

Some AI scribe companies give you the ability to insert a template (pre-designed blueprint) where you can tell the AI scribe your writing style. However, doctors won’t create a template. Unfortunately, we are still far behind. There are tons of doctors who don’t know what ChatGPT is.

The perfect AI scribe would be an AI model where I can feed it my last 10 medical notes, and it learns my writing style and crafts a note depending on that.”

Source: Roupen Odabashian/LinkedIn

Dr. Roupen Odabashian is an accomplished Internal Medicine Physician and Hematology/Oncology Fellow with a profound commitment to advancing healthcare through clinical practice, research, and technology. Currently based at the prestigious Karmanos Cancer Institute, Dr. Odabashian is actively involved in pioneering cancer treatments and conducting clinical research.

In addition to his clinical work, Dr. Odabashian is a multifaceted healthcare professional. He hosts podcast at OncoDaily, engaging with leading experts in oncology to share valuable insights with the medical community. Dr. Odabashian also contributes his expertise as an advisor at Spiraldot Health and Mesh AI, supporting innovative ventures in healthcare technology and collaborative scheduling to combat clinician burnout. With his diverse roles and unwavering dedication, Dr. Odabashian exemplifies a commitment to driving positive change in healthcare.

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”